Home › Funds › DRIEHAUS CAPITAL MANAGEMENT LLC › EWTX

DRIEHAUS CAPITAL MANAGEMENT LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

DRIEHAUS CAPITAL MANAGEMENT LLC reported holding 4,401,906 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$178.7M, representing 1.24% of its reported portfolio and ranking #8 among its reported holdings. DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)4.40M sh
Reported value held$178.72M
Portfolio Weight1.24%
First reportedQ4 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How DRIEHAUS CAPITAL MANAGEMENT LLC's EWTX position evolved

DRIEHAUS CAPITAL MANAGEMENT LLC first disclosed a stake in EWTX in Q4 2023 at 395,069 shares (US$4.3M). The position peaked in Q2 2026 at 4,728,623 shares, worth US$192.1M. Across 12 filings, DRIEHAUS CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,401,906 shares valued at US$178.7M — a reduction of -326,717 shares quarter over quarter.. Notable position changes include a 221% increase in Q1 2024 (shares fell 1% over the following quarter), a 55% increase in Q3 2024 (shares were roughly flat over the following quarter), a 88% increase in Q4 2025 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 395.07K $4.32M New
Q1 2024 1.27M $23.13M Add
Q2 2024 1.26M $22.70M Reduce
Q3 2024 1.95M $52.14M Add
Q4 2024 1.49M $39.88M Reduce
Q1 2025 1.38M $30.27M Reduce
Q2 2025 2.10M $27.55M Add
Q3 2025 2.23M $36.14M Add
Q4 2025 4.19M $104.00M Add
Q1 2026 4.48M $141.06M Add
Q2 2026 4.73M $192.12M Add
Q3 2026 4.40M $178.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has DRIEHAUS CAPITAL MANAGEMENT LLC held EWTX?

DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in EWTX?

As of Q3 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.40M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $178.72M, representing 1.24% of its reported portfolio and ranking #8.

Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in EWTX. The position peaked in Q2 2026 at 4.73M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.